01 1PolyPeptide Laboratories France
01 1ZILUCOPLAN
01 1Switzerland
NDC Package Code : 59162-0000
Start Marketing Date : 2023-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Zilucoplan Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zilucoplan Sodium, including repackagers and relabelers. The FDA regulates Zilucoplan Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zilucoplan Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zilucoplan Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zilucoplan Sodium supplier is an individual or a company that provides Zilucoplan Sodium active pharmaceutical ingredient (API) or Zilucoplan Sodium finished formulations upon request. The Zilucoplan Sodium suppliers may include Zilucoplan Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Zilucoplan Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zilucoplan Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zilucoplan Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zilucoplan Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zilucoplan Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zilucoplan Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zilucoplan Sodium suppliers with NDC on PharmaCompass.
We have 1 companies offering Zilucoplan Sodium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
